NFE2L2 and Parkinson disease: Diseases associated with oxidative stress, such as Alzheimer’s and Parkinson’s, often exhibit impaired Nrf2 (nuclear factor erythroid 2-related factor [16]) signaling, which facilitates cancer cell survival and resistance to chemotherapy [17,18,19].